Suppression of plant RNA silencing is a mechanism which pathogens (e.g. viruses) use for survival. In general, viruses carry genes encoding silencing suppressor proteins which can either bind to small RNAs (sRNAs) (Silhavy et al., 2002; Kasschau et al., 2003) , interfere with Argonaute proteins or Dicer-like and/or probably with Hua Enhancer 1 (HEN1) (Csorba et al., 2010; Jin & Zhu, 2010; Wu et al., 2010 . The helper component-proteinase (HC-Pro) is a multifunctional protein that plays multiple roles in the life cycle of potyviruses. It exhibits silencing suppressor activity by binding sRNA duplexes, e.g. small interfering RNA (siRNAs) and microRNAs (miRNA), rendering these RNAs inactive (Mérai et al., 2006; Shiboleth et al., 2007) . In addition, using a yeast-twohybrid system, binding of HC-Pro to a host protein, the Calmodulin-related protein, rgs-CaM from Nicotiana tabacum, was reported (Anandalakshmi et al., 2000) .
The RNA methyltransferase HEN1 is responsible for the 39-terminal 29-O-methylation of sRNAs in Arabidopsis , Drosophila (Horwich et al., 2007; Saito et al., 2007) and mouse (Kirino & Mourelatos, 2007) . Arabidopsis HEN1 (AtHEN1) methylates double-stranded sRNAs Yang et al. 2006) , probably before they are loaded onto Argonaute proteins (Ramachandran & Chen, 2008a; Fang & Spector, 2007) . This 29-O-methylation protects sRNAs from exonuclease degradation (Ramachandran & Chen, 2008b) . The loss of this modification causes a general reduction in the levels of sRNAs in plants (Boutet et al., 2003; Li et al., 2005) . Although HEN1 was assumed to be exclusively localized in the nucleus (Xie et al., 2004) , it was also recently found in the cytoplasm (Csorba et al., 2007) .
Transgenic Arabidopsis plants expressing Turnip mosaic virus (TuMV) P1/HC-Pro differentially methylated miRNAs . It was proposed that HC-Pro may prevent HEN1 from interacting with duplexes or block it from accessing the 29-OH of the 39-terminal nucleotide. Alternatively, HC-Pro may bind directly to HEN1 and inhibit its activity . Here, we report for the first time that Zucchini yellow mosaic virus (ZYMV) HC-Pro inhibits the methylase activity of HEN1 in vitro. prepared as described previously (Fuellgrabe et al., 2011) . To identify the HEN1-binding domain in the HC-Pro protein, different N-and C-termini truncated (D) HC-Pro constructs were generated ( Supplementary Fig. S1 , available in JGV Online) (Laible & Boonrod, 2009 ).
Protein expression and purification were carried out according to Fuellgrabe et al. (2011) Fig. S2 , available in JGV Online). In addition to the full-length protein (99 kDa), a lower molecular mass fragment of about 55 kDa was detectable in all preparations. The 55 kDa protein was probably a bacterial protein co-purified with the HC-Pro proteins (Fuellgrabe et al., 2011 ).
An ELISA was carried out in order to check the in vitro binding of HC-Pro FRNK/FINK with AtHEN1, and to determine the binding site of HC-Pro FRNK with AtHEN1. A microtitre plate was coated with 50 U AtHEN1 RNA methyltransferase (cloned from Arabidopsis plants with a physical purity of 95 %; NEB) diluted in 100 ml 3 % BSA in PBS buffer. The plate was incubated at 4 u C overnight. Non-specific binding was blocked with 3 % BSA in PBS buffer for 1 h. The plate was then washed three times with PBS buffer, then equal amounts (~0.5 mg) of MBP : HA-HC-Pro FRNK/FINK and all DN/DC-MBP : HA-HC-Pro FRNK deletion mutant proteins diluted in 100 ml of 3 % BSA in PBS buffer were added. MBP was used as a negative control for HC-Pro, while the total bacterial soluble proteins [noninduced BL21(DE3) codon + ] were used as negative control for AtHEN1. The plate was incubated at room temperature (RT) for 2 h. Unbound protein was washed out four times with 0.001 % Tween-PBS buffer and once with PBS buffer. Binding of AtHEN1 to HC-Pro was detected by ELISA with 1 : 10 000 of anti-MBP HRP conjugate (NEB) specific for the MBP and 1 : 2000 of anti-mouse antibody conjugated with alkaline phosphatase (AP; Sigma-Aldrich). Finally, fresh substrate was added to the plates followed by incubation at 37 u C for 15 min. The absorbance was then measured using a plate reader (Multiscan Ascent) at 405 nm for the detection of protein-protein interaction.
In order to demonstrate direct binding of HC-Pro to AtHEN1, a microtitre plate was coated either with AtHEN1 (50 U) or total bacterial soluble proteins [1 mg of noninduced BL21 (DE3) (Fig. 1) . The lower binding of MBP : HA-HC-Pro FINK implied that the arginine in the FRNK box may play a role not only in binding to siRNA (Shiboleth et al., 2007; Fuellgrabe et al., 2011) , but also to AtHEN1. The lower binding between HC-Pro and total bacterial proteins (about threefold) indicated the specificity of binding between HC-Pro and AtHEN1.
In order to identify the binding domain of HC-Pro to AtHEN1, deletions in the N and C termini of HC-Pro FRNK were generated as described above (Supplementary Fig.  S1 ). Two micrograms of each protein fraction were used for a HEN1-binding assay using ELISA. With one exception the deletion of either the N or the C terminus of HC-Pro strongly reduces AtHEN1 binding (Fig. 2 ). Interestingly DC7, in which most of the HC-Pro C terminus was deleted, showed strong binding to AtHEN1. This strong binding could be due to folding of the HC-Pro DC7 that would promote an efficient exposition of the HCPro domain interacting with AtHEN1. This result suggests that the HC-Pro-AtHEN1 interaction requires proper folding more than the structure of the protein for the strong binding (Atreya & Pirone, 1993) . Our data did not enable us to identify the HC-Pro-binding domain at the amino acid level. Due to the observation that all N-and, with the exception of HC-Pro DC7, all other C-terminal HC-Pro deletions led to a loss of interaction with AtHEN1, we assume that the putative-binding domain of HC-Pro is located close to the centre of the protein between positions 139 and 320 of ZYMV HC-Pro. Alternatively, one may speculate that an N-and a C-terminal domain of HC-Pro are both required for AtHEN1 binding. However, the observation that HC-Pro DC7 strongly bound to AtHEN1 argues against this hypothesis.
A methyltransferase inhibition assay was carried out to analyse the effect of the ZYMV HC-Pro on HEN1 activity. The inhibition assay was performed according to Yu et al. (2005) with some modifications. The reaction was carried out with 100 ml of total reaction mixture that contained 16 NEB 2 buffer (NEB), 1 mg miR173 (Sigma-Aldrich), 2 ml Ribo Lock RNase-Inhibitor (40 U ml 21 ; Fermentas), 2 ml AtHEN1 RNA methyltransferase, 4 ml S-adenosyl-L-[methyl- . After 1 h of incubation at 37 u C, the reaction was stopped by the addition of 100 ml stopping solution [100 mM Tris/HCl (pH 8.0), 10 mM EDTA, 150 mM NaCl, 2 % SDS and 0.4 mg proteinase K ml
21
] and incubation for 15 min at 65 u C. The reaction was extracted with phenol/chloroform and the RNA was precipitated by adding 3 ml glycogen and 300 ml 2-propanol, 10 M ammonium acetate (10 : 2) followed by incubation for 1 h at 220 u C for RNA precipitation. The reaction mixture was washed with 70 % ethanol (220 u C) and the pellet was dried for 10 min at RT before it was resuspended in 10 ml RNase-free water. RNA samples were electrophoresed at 80 V in 16 TBE buffer using a 20 % TBE-polyacrylamide gel (www.anamed-gel.com). The gel was dried at 65 u C for 1 h, exposed to FujiFilm Imaging Plates (Fujifilm) and scanned using PharosFX Plus PhosphorImager (Bio-Rad).
HEN1 has an S-adenosyl methionine (SAM)-binding pocket and can methylate the 39-terminal 29-O-methylation of sRNAs . It was clear from our ELISA results that MBP : HA-HC-Pro FRNK/FINK can bind to AtHEN1. To test whether HC-Pro can inhibit the methlytransferase activity of HEN1 in vitro, a methyltransferase inhibition assay was performed as described above using adenosyl-14 C. In such an assay, the incorporation of labelled methyl-14 C in the 39 end of RNA templates can be detected (Kurth & Mochizuki, 2009 ). Purified MBP : HA-HC-Pro FRNK/FINK and the truncated proteins DN1 and DC9 were incubated with AtHEN1. To exclude that the possible impurities in the protein preparation, including the copurified 55 kDa protein ( Supplementary Fig. S2 ), could inhibit the AtHEN1 activity the total soluble bacterial proteins [non-induced BL21(DE3) codon + ] were included in the assay. Subsequently, a synthetic miRNA duplex of 22 bp whose 39 ends carried a 29-hydroxyl and S-adenosyl-L[methyl-14 C] methionine, which served as a methyl group donor, were added. The methyltransferase inhibition assay showed that HC-Pro FRNK/FINK clearly inhibited AtHEN1 activity in vitro (Fig. 3) . It is worth noting that the total bacterial extracts did not inhibit the AtHEN1 activity. This indicated that no interaction between bacterial proteins and AtHEN1 occurred. This result also argued against the binding of putative protein contaminants (Fig. 1) to AtHEN1.
It was shown that the FRNK box in the central domain of HC-Pro, which is highly conserved among all sequenced members of the genus Potyvirus, is required for binding of double-stranded sRNA duplexes and that replacement of arginine at position 180 (R180) by leucine (I) within this sequence impaired sRNA binding and led to the attenuation of the ZYMV infection symptoms (Shiboleth et al., 2007) . There is evidence suggesting that HC-Pro affected HEN1 activity in vivo resulting in the suppression of RNAmediated silencing. However, the mechanism of HEN1 interference by HC-Pro has not yet been demonstrated. The finding that mutating the FRNK box of HC-Pro results in its loss of sRNA-binding activity, even though silencing suppression remains (Shiboleth et al., 2007) prompted us to further investigate the silencing suppression function of HC-Pro.
Our results show that HC-Pro
, but not the truncated proteins (DN1 and DC9) displaying decreased in vitro affinity for AtHEN1 binding, have inhibited the methyltransferase activity of AtHEN1 in vitro. It was proposed that HC-Pro could bind to sRNA and subsequently protect HEN1 from sRNA templates . Other work (Ló zsa et al., 2008) has shown varying effects of some RNA silencing suppressors on siRNA 39 modification in Nicotiana benthamiana plants infected with viruses expressing RNA silencing suppressors, namely the p19 protein of Carnation Italian ringspot virus (CIRV) and the HC-Pro of Tobacco etch virus (TEV). The effects ranged from slight modification by CIRV to significant inhibition of si/miRNA modifications by TEV. It was proposed that HC-Pro covers the 39 overhangs of sRNAs, resulting in inhibition of 39 modifications by blocking HEN1 accessibility to sRNA. Alternatively, it was speculated that HC-Pro competes with HEN1 (Ló zsa et al., 2008). However, it was shown that HC-Pro FINK lost sRNAbinding activity in vitro and in vivo but retained its silencing suppressor activity (Fuellgrabe et al., 2011; Shiboleth et al. 2007 ). Thus, our results strongly indicate that inhibition of AtHEN1 activity by HC-Pro FRNK/FINK is probably due to direct interaction between both proteins. It can therefore be concluded that HEN1 inhibition and sRNA-binding activities of HC-Pro are independent of each other.
However, further work is needed to identify the binding domain of HC-Pro with HEN1 at the amino acid level and also to confirm the interaction in living plant cells. 14 C] methionine and incubated for 1 h at 37 6C. RNA samples were separated using 20 % TBE-polyacrylamide gels. The gels were dried and scanned using PharosFX Plus PhosphorImager.
